Jun 29, 2026 12:25PM
Jun 29, 2026 09:50AM
Jun 29, 2026 09:28AM
Jun 29, 2026 07:09AM
Jun 29, 2026 04:47AM
Jun 26, 2026 06:00PM
Jun 26, 2026 06:00PM Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
May 29, 2026 12:07PM
May 5, 2026 07:01AM
May 5, 2026 07:00AM
May 5, 2026 07:00AM
Mar 30, 2026 07:02AM
Mar 30, 2026 07:01AM
Feb 26, 2026 07:01AM Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
Jan 7, 2026 01:03AM
Jan 6, 2026 07:02AM
Jan 6, 2026 07:01AM
Dec 22, 2025 07:01AM
Dec 22, 2025 07:00AM
Dec 19, 2025 09:06AM
Dec 18, 2025 03:57AM Goldman on Viridian (VRDN): 'believes the market can potentially grow ~2-3x at peak due to veli's and '003's potential to expand use in chronic TED'
Nov 6, 2025 04:26AM
Nov 5, 2025 07:01AM
Nov 3, 2025 08:34AM
Nov 3, 2025 07:01AM
Oct 21, 2025 06:47AM
Oct 20, 2025 07:30AM
Sep 15, 2025 07:02AM Viridian completes enrollment in phase 3 thyroid eye disease trials
Sep 15, 2025 07:01AM
Aug 6, 2025 06:30AM
May 20, 2025 07:01AM
May 20, 2025 07:00AM
May 7, 2025 04:31PM
May 7, 2025 04:15PM
May 6, 2025 07:00AM Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2025 Financial Results
Aug 14, 2024 03:58PM
Jun 11, 2024 06:00AM
May 9, 2024 06:55AM
May 9, 2024 06:55AM
May 8, 2024 07:00AM
Jul 10, 2023 04:01PM
Jul 10, 2023 04:01PM Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)
May 9, 2023 04:01PM
Mar 8, 2023 07:00AM
Nov 30, 2022 10:39AM
Nov 30, 2022 09:34AM
Nov 14, 2022 06:59AM
Nov 14, 2022 06:59AM
Mar 10, 2022 04:05PM Viridian Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Updates
Jan 31, 2022 07:01AM

325,591 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All